Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 682

Sort by

Sort Order Select

Journal Articles

Guideline concordance of aspirin use for primary prevention in adult outpatients

Naina Chipalkatti, Geoffrey D. Barnes, Linda Bashaw, Adam Davie, Jennifer J. Griggs, Molly Harrod, Jacob E. Kurlander, Christine Medaugh, Rebeca Packard, Corey Powell, Suman Sood, Elizabeth Spranger, Sarah E. Vordenberg, Jordan K. Schaefer

Blood Adv (2024) 8 (24): 6207–6214.

https://doi.org/10.1182/bloodadvances.2024014220

Published: 2024

Includes: Supplemental data

Journal Articles

Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis

Michael Andersen, Jr., Maria J. Fernandez Turizo, Laura E. Dodge, Charles Hsu, Kevin Barnum, Jonathan Berry, Jeffrey I. Zwicker, Rushad Patell

Blood Adv (2024) 8 (24): 6151–6160.

https://doi.org/10.1182/bloodadvances.2024014249

Published: 2024

Includes: Supplemental data

Journal Articles

Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody-induced immunothrombosis

Tamam Bakchoul, Jan Zlamal, Vera Ripoll Nunez, Dr., Christine Shu Mei Lee, Filip Toma, Karina Althaus, Flavianna Rigoni, Vivien M Chen, Shane Whittaker, Andreas Witzemann, Günalp Uzun, David Capraro

Blood Adv bloodadvances.2024014167.

https://doi.org/10.1182/bloodadvances.2024014167

Published: 2024

Includes: Supplemental data

Journal Articles

Cost-Effectiveness of Voncento Prophylaxis Versus On-Demand Treatment in von Willebrand Disease in the United Kingdom

Michele R Wilson, Giancarlo Castaman, William Thomas, Carolyn M Millar, Gines Escolar, Wolfgang A. Miesbach, Cheryl L McDade, Radovan Tomic, Songkai Yan

Blood Adv bloodadvances.2024014376.

https://doi.org/10.1182/bloodadvances.2024014376

Published: 2024

Journal Articles

Membrane-bound model of the ternary complex between factor VIIa/tissue factor and factor X

Melanie P Muller, Alex Mortenson, Josepha C Sedzro, Po-Chao Wen, James H Morrissey, Emad Tajkhorshid

Blood Adv bloodadvances.2024014845.

https://doi.org/10.1182/bloodadvances.2024014845

Published: 2024

Includes: Supplemental data

Journal Articles

Loss of protein C vs protein S results in discrepant thrombotic phenotypes

Chia-Jui Ku, Xinge Yu, Queena Yakun Zhao, Steven J Grzegorski, Jeffrey G Daniel, Allison C Ferguson, Jordan A Shavit

Blood Adv bloodadvances.2024013237.

https://doi.org/10.1182/bloodadvances.2024013237

Published: 2024

Includes: Multimedia, Supplemental data

Journal Articles

Gene therapy for hemophilia

Peter J. Lenting, Sylvia Fong

Blood Adv (2024) 8 (23): 6081.

https://doi.org/10.1182/bloodadvances.2024013864

Published: 2024

Journal Articles

Generalized Additive Logit Models for Clinical Prediction

Cameron Norman McIntosh

Blood Adv bloodadvances.2024014929.

https://doi.org/10.1182/bloodadvances.2024014929

Published: 2024

Journal Articles

Optical genome mapping identified deletions, inversions, and insertions in hemophilia

Boyan Liu, Lu Zhou, Lijuan Cao, Liu Haoning, Laigen Tong, Zichang Zhang, Hongjie Shen, Changgeng Ruan, Zhou Yafeng, Miao Jiang

Blood Adv bloodadvances.2024014762.

https://doi.org/10.1182/bloodadvances.2024014762

Published: 2024

Includes: Supplemental data

Journal Articles

Adeno-associated virus–based gene therapy for hemophilia A and B: a systematic review and meta-analysis

Saarang R. Deshpande, Keerthy Joseph, Jiayi Tong, Yong Chen, Allyson Pishko, Adam Cuker

Blood Adv (2024) 8 (23): 5957–5974.

https://doi.org/10.1182/bloodadvances.2024014111

Published: 2024

Includes: Supplemental data

Journal Articles

CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease

Angela Todorovski, Tzu-Fei Wang, Marc Carrier, Yan Xu

Blood Adv bloodadvances.2024014430.

https://doi.org/10.1182/bloodadvances.2024014430

Published: 2024

Journal Articles

Handling delayed or missed direct oral anticoagulant doses: model-informed individual remedial dosing

Xiao-Qin Liu, Zi-Ran Li, Chen-Yu Wang, Zheng Jiao

Blood Adv (2024) 8 (22): 5906–5916.

https://doi.org/10.1182/bloodadvances.2024013854

Published: 2024

Includes: Supplemental data

Journal Articles

Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort

Jacqueline N. Poston, Cassandra Bryan, Annette von Drygalski, Kadhim Al Banaa, Jenny Y. Zhou, Aric Parnes, Evan C. Chen, Osman Khan, Patrick Ellsworth, Lorraine Cafuir, Christopher Walsh, Miguel A. Escobar, James F. Wu, Lynn M. Malec, Craig M. Kessler, Maissaa Janbain, Rebecca Kruse-Jarres

Blood Adv (2024) 8 (22): 5896–5905.

https://doi.org/10.1182/bloodadvances.2024013882

Published: 2024

Includes: Supplemental data

Journal Articles

Platelet Ido1 expression is induced during Plasmodium yoelii infection, altering plasma tryptophan metabolites

Sara K. Blick-Nitko, Sara K. Ture, Xenia L. Schafer, Joshua C. Munger, Alison C. Livada, Chen Li, Preeti Maurya, Matthew T. Rondina, Craig N. Morrell

Blood Adv (2024) 8 (22): 5814–5825.

https://doi.org/10.1182/bloodadvances.2024013175

Published: 2024

Includes: Supplemental data

Journal Articles

Predictors of liver disease outcomes in individuals with hemophilia and HCV infection

Ilias Christodoulou, Scott Rothenberger, Margaret V. Ragni

Blood Adv (2024) 8 (22): 5767–5772.

https://doi.org/10.1182/bloodadvances.2024014350

Published: 2024

Journal Articles

Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial

Marisol Betensky, Maua Mosha, Cristina Tarango, Anupam Verma, Rukhmi Bhat, Nicole E. Kucine, Taizo Nakano, Charles Nakar, Gary Woods, Ernest Amankwah, Leonardo R. Brandão, Sam Schulman, Neil A. Goldenberg

Blood Adv (2024) 8 (22): 5790–5795.

https://doi.org/10.1182/bloodadvances.2024014415

Published: 2024

Includes: Supplemental data

Journal Articles

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Halina H. L. Leung, Zohra Ahmadi, Brendan Lee, John Casey, Sumita Ratnasingam, Steven E. McKenzie, Jose Perdomo, Beng H. Chong

Blood Adv (2024) 8 (22): 5744–5752.

https://doi.org/10.1182/bloodadvances.2024013883

Published: 2024

Includes: Supplemental data

Journal Articles

Use of Affimer Technology for Inhibition of α2-antiplasmin and Enhancement of Fibrinolysis

Nikoletta Pechlivani, Basmah Alsayejh, Mansour Khalaf Almutairi, Katie Simmons, Thembaninkosi Gaule, Fladia Phoenix, Noppadol Kietsiriroje, Sreenivasan Ponnambalam, Cedric Duval, Robert A S Ariëns, Christian Tiede, Darren C. Tomlinson, Ramzi Ajjan

Blood Adv bloodadvances.2024014235.

https://doi.org/10.1182/bloodadvances.2024014235

Published: 2024

Includes: Supplemental data

Journal Articles

Plasmin generation analysis in patients with bleeding disorder of unknown cause

Dino Mehic, Stéphanie E. Reitsma, Claire de Moreuil, Helmuth Haslacher, Maximilian C. Koeller, Bas de Laat, Cihan Ay, Ingrid Pabinger, Alisa S. Wolberg, Johanna Gebhart

Blood Adv (2024) 8 (21): 5663–5673.

https://doi.org/10.1182/bloodadvances.2024012855

Published: 2024

Includes: Supplemental data

Journal Articles

Divergent Modulation of Activated Protein C Pleiotropic Functions by Antibodies That Differ by A Single Amino Acid

Derek S Sim, Meenal Shukla, Cornell R Mallari, José A. Fernández, Xiao Xu, Douglas Schneider, Maxine Bauzon, Terry W Hermiston, Laurent O. Mosnier

Blood Adv bloodadvances.2024013584.

https://doi.org/10.1182/bloodadvances.2024013584

Published: 2024

Includes: Supplemental data

NARROW

Guideline concordance of aspirin use for primary prevention in adult outpatients

Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis

Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody-induced immunothrombosis

Cost-Effectiveness of Voncento Prophylaxis Versus On-Demand Treatment in von Willebrand Disease in the United Kingdom

Membrane-bound model of the ternary complex between factor VIIa/tissue factor and factor X

Loss of protein C vs protein S results in discrepant thrombotic phenotypes

Gene therapy for hemophilia

Generalized Additive Logit Models for Clinical Prediction

Optical genome mapping identified deletions, inversions, and insertions in hemophilia

Adeno-associated virus–based gene therapy for hemophilia A and B: a systematic review and meta-analysis

CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease

Handling delayed or missed direct oral anticoagulant doses: model-informed individual remedial dosing

Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort

Platelet Ido1 expression is induced during Plasmodium yoelii infection, altering plasma tryptophan metabolites

Predictors of liver disease outcomes in individuals with hemophilia and HCV infection

Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Use of Affimer Technology for Inhibition of α2-antiplasmin and Enhancement of Fibrinolysis

Plasmin generation analysis in patients with bleeding disorder of unknown cause

Divergent Modulation of Activated Protein C Pleiotropic Functions by Antibodies That Differ by A Single Amino Acid

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only